The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125021194 12502119 4 F 200312 20160706 20160627 20160706 EXP CA-PFIZER INC-2016299146 PFIZER 18.00 YR F Y 0.00000 20160706 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125021194 12502119 1 SS ENBREL ETANERCEPT 1 Subcutaneous 25 MG, 2 TIMES/WK 0 25 MG BIW
125021194 12502119 2 SS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, QWK 0 50 MG /wk
125021194 12502119 3 SS ENBREL ETANERCEPT 1 Subcutaneous 25 MG, WEEKLY 0 25 MG /wk
125021194 12502119 4 SS ENBREL ETANERCEPT 1 Subcutaneous 25 MG, 2X/WEEK 0 25 MG BIW
125021194 12502119 5 SS ENBREL ETANERCEPT 1 Subcutaneous 25 MG, WEEKLY 0 25 MG /wk
125021194 12502119 6 SS ENBREL ETANERCEPT 1 50 MG, UNK 0 50 MG
125021194 12502119 7 PS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, QWK 11719 25 MG /wk
125021194 12502119 8 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 20 MG, QWK 11719 20 MG /wk
125021194 12502119 9 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, QWK 11719 25 MG /wk
125021194 12502119 10 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 17.5 MG, QWK (0.75ML) 11719 17.5 MG /wk
125021194 12502119 11 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral 25 MG, WEEKLY 11719 25 MG /wk
125021194 12502119 12 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 25 MG, QWK 11719 25 MG /wk
125021194 12502119 13 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 17.5 UNK, UNK 11719 17.5 MG
125021194 12502119 14 SS RITUXIMAB RITUXIMAB 1 0
125021194 12502119 15 SS SIMPONI GOLIMUMAB 1 Subcutaneous 50 MG, MONTHLY 0 50 MG /month
125021194 12502119 16 SS ACTEMRA TOCILIZUMAB 1 MONTHLY INFUSIONS 0 /month
125021194 12502119 17 SS ARAVA LEFLUNOMIDE 1 Unknown 10 MG, DAILY 0 10 MG
125021194 12502119 18 C NAPROSYN NAPROXEN 1 Unknown 375 MG, 1X/DAY, AS NEEDED 0 375 MG QD
125021194 12502119 19 C NAPROSYN NAPROXEN 1 Unknown 375 MG, TWICE DAILY AS NEEDED 0 375 MG BID
125021194 12502119 20 C FOLIC ACID. FOLIC ACID 1 Unknown 1 MG, 6 DAYS PER WEEK 0 1 MG
125021194 12502119 21 C FOLIC ACID. FOLIC ACID 1 Unknown 5 MG, 2 TIMES/WK 0 5 MG BIW
125021194 12502119 22 C DEPO-MEDROL METHYLPREDNISOLONE ACETATE 1 60 MG, UNK 0 60 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125021194 12502119 1 Rheumatoid arthritis
125021194 12502119 7 Rheumatoid arthritis
125021194 12502119 14 Rheumatoid arthritis
125021194 12502119 15 Rheumatoid arthritis
125021194 12502119 16 Rheumatoid arthritis
125021194 12502119 17 Rheumatoid arthritis
125021194 12502119 18 Rheumatoid arthritis
125021194 12502119 19 Discomfort

Outcome of event

Event ID CASEID OUTC COD
125021194 12502119 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125021194 12502119 Activities of daily living impaired
125021194 12502119 Arthralgia
125021194 12502119 Arthritis
125021194 12502119 Bone disorder
125021194 12502119 Bone erosion
125021194 12502119 Condition aggravated
125021194 12502119 Diarrhoea
125021194 12502119 Discomfort
125021194 12502119 Drug ineffective
125021194 12502119 Drug intolerance
125021194 12502119 Foot deformity
125021194 12502119 Inflammation
125021194 12502119 Joint crepitation
125021194 12502119 Joint effusion
125021194 12502119 Joint range of motion decreased
125021194 12502119 Joint swelling
125021194 12502119 Limb discomfort
125021194 12502119 Musculoskeletal discomfort
125021194 12502119 Musculoskeletal stiffness
125021194 12502119 Neck pain
125021194 12502119 Pain in extremity
125021194 12502119 Peripheral swelling
125021194 12502119 Rheumatoid nodule
125021194 12502119 Synovial cyst
125021194 12502119 Synovitis
125021194 12502119 Treatment failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125021194 12502119 1 200501 200809 0
125021194 12502119 2 20090619 0
125021194 12502119 3 20080912 0
125021194 12502119 4 200809 0
125021194 12502119 6 2008 2009 0
125021194 12502119 7 2002 2005 0
125021194 12502119 8 2005 20050912 0
125021194 12502119 9 20050912 20100804 0
125021194 12502119 10 20100804 0
125021194 12502119 12 20131007 0
125021194 12502119 13 2003 0
125021194 12502119 15 2010 20160520 0
125021194 12502119 16 2013 0
125021194 12502119 17 20131007 0
125021194 12502119 18 20080912 0
125021194 12502119 19 20080912 0
125021194 12502119 20 20090619 0
125021194 12502119 21 20090619 0